S&P 500   3,347.20 (+0.35%)
DOW   27,638.18 (+0.68%)
QQQ   279.21 (+1.18%)
AAPL   116.44 (+2.06%)
MSFT   210.82 (+1.72%)
FB   263.24 (+0.55%)
GOOGL   1,477.48 (+0.78%)
AMZN   3,164.31 (+0.62%)
TSLA   429.68 (+2.53%)
NVDA   543.13 (+2.67%)
BABA   292.82 (+5.74%)
CGC   14.40 (-0.69%)
MU   47.42 (-6.49%)
GE   6.22 (+1.63%)
AMD   82.54 (+0.94%)
T   28.42 (+0.42%)
F   6.64 (+0.61%)
ACB   4.68 (+0.00%)
GILD   63.01 (+1.47%)
NFLX   500.75 (+1.47%)
DIS   124.35 (-0.84%)
BA   166.27 (+1.63%)
BAC   24.08 (+1.30%)
S&P 500   3,347.20 (+0.35%)
DOW   27,638.18 (+0.68%)
QQQ   279.21 (+1.18%)
AAPL   116.44 (+2.06%)
MSFT   210.82 (+1.72%)
FB   263.24 (+0.55%)
GOOGL   1,477.48 (+0.78%)
AMZN   3,164.31 (+0.62%)
TSLA   429.68 (+2.53%)
NVDA   543.13 (+2.67%)
BABA   292.82 (+5.74%)
CGC   14.40 (-0.69%)
MU   47.42 (-6.49%)
GE   6.22 (+1.63%)
AMD   82.54 (+0.94%)
T   28.42 (+0.42%)
F   6.64 (+0.61%)
ACB   4.68 (+0.00%)
GILD   63.01 (+1.47%)
NFLX   500.75 (+1.47%)
DIS   124.35 (-0.84%)
BA   166.27 (+1.63%)
BAC   24.08 (+1.30%)
S&P 500   3,347.20 (+0.35%)
DOW   27,638.18 (+0.68%)
QQQ   279.21 (+1.18%)
AAPL   116.44 (+2.06%)
MSFT   210.82 (+1.72%)
FB   263.24 (+0.55%)
GOOGL   1,477.48 (+0.78%)
AMZN   3,164.31 (+0.62%)
TSLA   429.68 (+2.53%)
NVDA   543.13 (+2.67%)
BABA   292.82 (+5.74%)
CGC   14.40 (-0.69%)
MU   47.42 (-6.49%)
GE   6.22 (+1.63%)
AMD   82.54 (+0.94%)
T   28.42 (+0.42%)
F   6.64 (+0.61%)
ACB   4.68 (+0.00%)
GILD   63.01 (+1.47%)
NFLX   500.75 (+1.47%)
DIS   124.35 (-0.84%)
BA   166.27 (+1.63%)
BAC   24.08 (+1.30%)
S&P 500   3,347.20 (+0.35%)
DOW   27,638.18 (+0.68%)
QQQ   279.21 (+1.18%)
AAPL   116.44 (+2.06%)
MSFT   210.82 (+1.72%)
FB   263.24 (+0.55%)
GOOGL   1,477.48 (+0.78%)
AMZN   3,164.31 (+0.62%)
TSLA   429.68 (+2.53%)
NVDA   543.13 (+2.67%)
BABA   292.82 (+5.74%)
CGC   14.40 (-0.69%)
MU   47.42 (-6.49%)
GE   6.22 (+1.63%)
AMD   82.54 (+0.94%)
T   28.42 (+0.42%)
F   6.64 (+0.61%)
ACB   4.68 (+0.00%)
GILD   63.01 (+1.47%)
NFLX   500.75 (+1.47%)
DIS   124.35 (-0.84%)
BA   166.27 (+1.63%)
BAC   24.08 (+1.30%)
Log in
NASDAQ:AMPH

Amphastar Pharmaceuticals Price Target, Predictions & Analyst Ratings

$18.67
+0.04 (+0.21 %)
(As of 09/30/2020 03:04 PM ET)
Add
Compare
Today's Range
$18.61
Now: $18.67
$19.00
50-Day Range
$17.99
MA: $19.72
$20.49
52-Week Range
$12.32
Now: $18.67
$22.69
Volume9,873 shs
Average Volume273,759 shs
Market Capitalization$886.56 million
P/E Ratio207.47
Dividend YieldN/A
Beta1

Analyst Ratings

Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
3 Wall Street analysts have issued ratings and price targets for Amphastar Pharmaceuticals in the last 12 months. Their average twelve-month price target is $22.00, predicting that the stock has a possible upside of 17.84%. The high price target for AMPH is $23.00 and the low price target for AMPH is $21.00. There are currently 3 hold ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
AMPH Consensus Rating: HoldHoldHoldBuy
AMPH Consensus Rating Score: 2.002.002.332.50
AMPH Analyst Ratings: 0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
AMPH Consensus Price Target: $22.00$22.00$22.00$29.00
AMPH Price Target Upside: 17.84% upside8.53% upside8.27% upside45.07% upside

Amphastar Pharmaceuticals (NASDAQ:AMPH) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Amphastar Pharmaceuticals (NASDAQ:AMPH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/7/2020Northland SecuritiesReiterated RatingHold$23.00High
6/10/2020Needham & Company LLCReiterated RatingHoldMedium
5/11/2020BMO Capital MarketsBoost Price TargetMarket Perform$20.00 ➝ $21.00High
6/6/2019Wells Fargo & CompanySet Price TargetBuy$29.00Low
3/13/2019Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$24.00 ➝ $23.00High
11/14/2018Jefferies Financial GroupReiterated RatingBuy$26.00Medium
11/9/2017Raymond JamesDowngradeOutperform ➝ Market Perform$18.00N/A
(Data available from 9/30/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 9/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.